BURNETT JOSEPH 4

What Happened
Joseph M. Burnett, CEO, President and a director of ClearPoint Neuro, settled 84,829 restricted stock units (RSUs) on March 12, 2026, resulting in the issuance/conversion of 84,829 shares. To satisfy tax withholding obligations, 43,161 of those shares were delivered back to ClearPoint at $11.53 per share, representing approximately $497,646. The transactions are reported as derivative exercises/conversions (code M) for the RSU settlement and a tax-withholding disposition (code F) for the withheld shares.

Key Details

• Transaction date: 2026-03-12; Form 4 filed 2026-03-16 (filed within the usual 2-business-day window).
• RSUs settled / shares issued: 84,829 shares (code M).
• Shares withheld for taxes: 43,161 shares at $11.53 per share, total ≈ $497,646 (code F).
• Footnotes: F1 = RSUs convert 1:1 to common shares on vesting; F2 = shares delivered to CLPT to satisfy tax withholding; F3 = the shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Burnett as trustee.
• The filing shows the RSU settlement and withholding; it does not report a cash open-market sale by Burnett.

Context
This was a routine RSU vesting and tax-withholding event — the RSUs converted into shares and a portion was surrendered to the company to cover taxes. Such tax-withholding dispositions are common and do not indicate an open-market sale or necessarily signal a change in insider sentiment. The ownership is reported via Burnett’s named trust (per footnote).